Delay In OTC Loratadine Coverage By Medicaid Caused “Lost Savings” – Study
This article was originally published in The Tan Sheet
Executive Summary
A state Medicaid program's failure to cover OTC Claritin (loratadine) immediately after its switch approval was a detriment to potential savings, a study evaluating the cost impact of OTC coverage concludes
You may also be interested in...
Arkansas Prilosec OTC Coverage Offers Savings Model For Plan Sponsors
An Arkansas state health plan that covers use ofPrilosec OTC provides a blueprint for plan sponsors looking to nonprescription drugs for cost savings
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation